The ETF is a multidisciplinary expert group established by Regulation (EU) No 2022/123 (hereinafter “the Regulation”) within the European Medicines Agency (hereinafter ‘the Agency’) in preparation for and during a health emergency to provide scientific advice and to review scientific data on medicinal products targeting the emergency, to provide recommendations with regards to the use of such medicinal products and to provide scientific support to facilitate clinical trials for such medicinal products.
It includes the co-chairs in addition to a number of members who shall be nominated based on expertise and convened as defined in these Rules of Procedures. The ETF shall perform its tasks as an advisory and support body separate from, and without prejudice to, the tasks of the scientific committees of the Agency as regards the authorisation, supervision and pharmacovigilance of the medicinal products concerned and related regulatory actions to ensure the quality, safety and efficacy of those medicinal products…
